DOI: 10.1055/s-00023610

Drug Research

Ausgabe 11 · Volume 66 · November 2016 DOI: 10.1055/s-006-32784

Review

562
van Niel, J. C. G.; Schneider, J.; Tzschentke, T. M.: Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists – Preclinical and Clinical Evidence
571
Majidinia, M.; Alizadeh, E.; Yousefi, B.; Akbarzadeh, M.; Zarghami, N.: Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment
580
Panahi, Y.; Mohammadhosseini, M.; Abadi, A. J. N.; Akbarzadeh, A.; Mellatyar, H.: An Update on Biomedical Application of Nanotechnology for Alzheimer’s Disease Diagnosis and Therapy

Original Article

587
Balaji, K.; Bhatt, P.; Jha, A.: Expeditious Synthesis, Antimicrobial and Antimalarial Activities of Novel Heterocycles Bearing Imidazole-oxadiazole Based Hybrid Pharmacophores
Supporting Information
592
Najibi, A.; Heidari, R.; Zarifi, J.; Jamshidzadeh, A.; Firoozabadi, N.; Niknahad, H.: Evaluating the Role of Drug Metabolism and Reactive Intermediates in Trazodone-Induced Cytotoxicity toward Freshly-Isolated Rat Hepatocytes
597
Alipour, M.; Fekrmandi, F.; Onsori, S.; Tabrizian, P.; Jafari, M. R.: The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice
603
Kusunoki, M.; Natsume, Y.; Sato, D.; Tsutsui, H.; Miyata, T.; Tsutsumi, K.; Suga, T.; Oshida, Y.: Luseogliflozin, A Sodium Glucose Co-transporter 2 Inhibitor, Alleviates Hepatic Impairment in Japanese Patients with Type 2 Diabetes
607
Rump, A.; Stricklin, D.; Lamkowski, A.; Eder, S.; Abend, M.; Port, M.: The Impact of Time on Decorporation Efficacy After a “Dirty Bomb” Attack Studied by Simulation

Short Communication

614
Zormann, A.; Blum, J.; Suenderhauf, C.; Vogel, M.; Walter, A.: Agomelatine and Transient Elevation of Creatine Phosphokinase